GB1416544A - Immunizing agents for bacterial infections - Google Patents

Immunizing agents for bacterial infections

Info

Publication number
GB1416544A
GB1416544A GB5250272A GB5250272A GB1416544A GB 1416544 A GB1416544 A GB 1416544A GB 5250272 A GB5250272 A GB 5250272A GB 5250272 A GB5250272 A GB 5250272A GB 1416544 A GB1416544 A GB 1416544A
Authority
GB
United Kingdom
Prior art keywords
lipoid
bacterial infections
nov
absorbed
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5250272A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of GB1416544A publication Critical patent/GB1416544A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1235—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1416544 Lipoid A preparations MAXPLANCK-GES ZUR FORDERUNG DER WISSENSOHAFTEN EV 14 Nov 1972 [17 Nov 1971] 52502/72 Heading A5B Immunization against bacterial infections may be provided by (i) lipoid A modified by treatment with dilute aq. NaOH or KOH, (ii) lipoid A absorbed on non-pathogenic Salmonella or Coli cells, (iii) alkali-modified lipoid A absorbed on non-pathogenic Salmonella or Coli cells or (iv) antiserum derived from lipoid A itself or any of the above forms (i)-(iii).
GB5250272A 1971-11-17 1972-11-14 Immunizing agents for bacterial infections Expired GB1416544A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (en) 1971-11-17 1971-11-17 IMMUNIZING PRODUCTS, METHOD OF MANUFACTURING AND ITS USES

Publications (1)

Publication Number Publication Date
GB1416544A true GB1416544A (en) 1975-12-03

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5250272A Expired GB1416544A (en) 1971-11-17 1972-11-14 Immunizing agents for bacterial infections

Country Status (10)

Country Link
JP (1) JPS5512002B2 (en)
AT (1) AT332539B (en)
BE (1) BE791489A (en)
CH (1) CH588867A5 (en)
DD (1) DD102410A5 (en)
DE (1) DE2157148A1 (en)
FR (1) FR2160542B1 (en)
GB (1) GB1416544A (en)
NL (1) NL7215221A (en)
SE (1) SE406419B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007861A2 (en) * 2003-07-14 2005-01-27 Uni-Klinikum Schleswig-Holstein Campus Kiel Method for the production and use of antimicrobial protein-inducing factors obtained from gram-negative bacteria
WO2014097154A1 (en) * 2012-12-20 2014-06-26 Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella "Immunolab" Sp. Z O.O. A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS581801U (en) * 1981-06-29 1983-01-07 日興電機工業株式会社 hydraulic unit
DE3516119A1 (en) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt POLYVALENT HYPERIMMIMMLOBULIN PREPARATE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (en) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Preparation of purified alpha lipid from crude alpha lipid derived from lipopolysaccharides of gram-negative bacteria

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007861A2 (en) * 2003-07-14 2005-01-27 Uni-Klinikum Schleswig-Holstein Campus Kiel Method for the production and use of antimicrobial protein-inducing factors obtained from gram-negative bacteria
WO2005007861A3 (en) * 2003-07-14 2005-06-23 Uni Klinikum Schleswig Holstei Method for the production and use of antimicrobial protein-inducing factors obtained from gram-negative bacteria
WO2014097154A1 (en) * 2012-12-20 2014-06-26 Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella "Immunolab" Sp. Z O.O. A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation

Also Published As

Publication number Publication date
ATA975872A (en) 1976-01-15
CH588867A5 (en) 1977-06-15
JPS5512002B2 (en) 1980-03-29
AU4902772A (en) 1974-05-23
SE406419B (en) 1979-02-12
DE2157148A1 (en) 1973-05-24
NL7215221A (en) 1973-05-21
AT332539B (en) 1976-10-11
DD102410A5 (en) 1973-12-12
BE791489A (en) 1973-05-16
FR2160542A1 (en) 1973-06-29
JPS4861621A (en) 1973-08-29
FR2160542B1 (en) 1976-04-23

Similar Documents

Publication Publication Date Title
GB1385342A (en) Ligand determination of spin labelled compounds by receptor displacement
GB1351263A (en) Eburnane derivatives
CA932626A (en) Composite method for growth of iib-via compounds on substrates, and process for making composition for the compounds
GB1322000A (en) Preparation of antiserum specific for a carcinoembryonic antigen
CA922877A (en) Yarn-piecing apparatus and method with yarn collation by vacuum
CA957536A (en) Two-part pull type positive lock fastener
GB1416544A (en) Immunizing agents for bacterial infections
GB1381585A (en) Air gun
FR2187301A1 (en) Alpha-6-deoxy-5-hydroxy tetracycline - by microbiological transformation of anhydro-5-hydroxy tetracycline
GB1415046A (en) 2-hydroxyethyl-2-hydroxydecalin
GB1378408A (en) Method of preparation 1-beta-d or l-arabinofuranosylcytosine
CA996935A (en) 2,9-dicarboxyquinacridone and methods for its production
CA997372A (en) Process for the production of alkylated n,n'-diphenyloxamides
GB1263677A (en) Process for the preparation of quinoxaline-di-n-oxide-aldehyde
CA977198A (en) Method for producing tagged zip fasteners
CA951310A (en) METHOD FOR THE PREPARATION OF 2.alpha.,3.alpha.-EPITHIO-5.alpha.-STEROIDS
ES401672A1 (en) 5,6-dihydro-8,8-dimethyl-3-nitro-8h imidazo(2-1-c) (1,4)oxazine
CA969175A (en) 6.alpha.,9.alpha.-DIFLUOROSTEROIDS OF THE PREGNANE SERIES AND PROCESSES FOR THEIR MANUFACTURE
AU2871771A (en) 4,5, & - oxido-bufa-dienolido-3- [rhamnosido-2',3'-dialkylortho-carbonates] and process for their manufacture
CA960649A (en) METHOD FOR THE PREPARATION OF 2.alpha.,3.alpha.-EPITHIO-5.alpha.-STEROIDS
GB1254948A (en) Antivirial substance
CA919697A (en) (3,4,5-trialkoxybenzoyl) amino-alkanoic acid, salts thereof and processes for producing same
GB1296179A (en)
CA852176A (en) Method of producing highly pure, especially silicon-free, gallium arsenide
CA851180A (en) 4'-HYDROXY (OR ACYLOXY)-(STEROID-2,5'-M-DIOXAN)-3-ONE, SPIRO(STEROID-2,3'(2'.alpha.)-PYRAZOLIN)-3-ONE, INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee